BN Business News
Add your company to Business Communicator →

Regulation & law · 07/12/1999Updated: 10/17/2026 · 1 min read

Recombinant DNA Advisory Committee Meeting Notice Amendment

Summary

The Recombinant DNA Advisory Committee will hold a meeting, following a request from the committee members, to discuss and propose updates to its schedule, in accordance with the National Institutes of Health guidelines, and in response to recent developments in the field of recombinant DNA technology.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights

Business insights →